Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant TEC and NAX in Breast Cancer
NCT00830544Phase 2Unknown
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Jul 2008
- Primary completion
- Dec 2011
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel, epirubicin, cyclophosphamide, vinorelbine, bevacizumab and 2 more in breast cancer, sponsored by Auxilio Mutuo Cancer Center. Status: unknown.
02
Drugs
docetaxelepirubicincyclophosphamidevinorelbinebevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00830544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830544.